|
THRAP3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.12450000000031E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.434900E-04 |
| Normal-vs-Stage2 |
9.036200E-04 |
| Normal-vs-Stage3 |
2.10229999999534E-05 |
| Normal-vs-Stage4 |
1.037160E-04 |
| Stage1-vs-Stage2 |
3.832400E-01 |
| Stage1-vs-Stage3 |
1.848780E-01 |
| Stage1-vs-Stage4 |
2.398400E-01 |
| Stage2-vs-Stage3 |
9.375400E-01 |
| Stage2-vs-Stage4 |
9.535200E-01 |
| Stage3-vs-Stage4 |
9.875400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.23469999999226E-05 |
| Normal-vs-AfricanAmerican |
4.586600E-01 |
| Normal-vs-Asian |
1.655710E-03 |
| Caucasian-vs-AfricanAmerican |
3.071600E-02 |
| Caucasian-vs-Asian |
9.703800E-01 |
| AfricanAmerican-vs-Asian |
6.077900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.87550000000569E-05 |
| Normal-vs-Female |
6.44530000000199E-05 |
| Male-vs-Female |
5.302800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.343550E-03 |
| Normal-vs-Age(41-60Yrs) |
8.22100000000825E-05 |
| Normal-vs-Age(61-80Yrs) |
1.63955999999965E-05 |
| Normal-vs-Age(81-100Yrs) |
1.366230E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.127800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.242240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.385400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.736600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.630800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.672800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.299600E-02 |
| Classical-VS-Follicular |
8.597400E-04 |
| Classical-VS-Other |
3.136200E-01 |
| Classical-VS-Normal |
1.519360E-03 |
| Tall-VS-Follicular |
4.610800E-01 |
| Tall-VS-Other |
8.983400E-01 |
| Tall-VS-Normal |
4.800200E-04 |
| Follicular-VS-Other |
8.253000E-01 |
| Follicular-VS-Normal |
1.95650000001102E-06 |
| Other-VS-Normal |
4.388400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.84031999999057E-05 |
| Normal-vs-N1 |
1.53942999999712E-05 |
| N0-vs-N1 |
2.814200E-01 |
|
|
